Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-16-031870
Filing Date
2016-05-13
Accepted
2016-05-13 17:06:42
Documents
1
Period of Report
2016-05-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3352
  Complete submission text file 0001437749-16-031870.txt   5009
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 170 N. RADNOR-CHESTER ROAD RADNOR PA 19087
Business Address
ANIDO ARMANDO (Reporting) CIK: 0001219866 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35285 | Film No.: 161649395